Scarica l'app Stockscreener
177.85
0.56%
-1.01
Dopo l'orario di chiusura:
177.85
Precedente Chiudi:
$178.86
Aprire:
$176.04
Volume 24 ore:
1.16M
Relative Volume:
1.20
Capitalizzazione di mercato:
$8.75B
Reddito:
$4.06B
Utile/perdita netta:
$413.08M
Rapporto P/E:
22.20
EPS:
8.01
Flusso di cassa netto:
$560.48M
1 W Prestazione:
-5.36%
1M Prestazione:
+0.29%
6M Prestazione:
+50.14%
1 anno Prestazione:
-2.54%
Intervallo 1D:
$175.83
$180.19
Intervallo di 1 settimana:
$173.89
$191.41
Portata 52W:
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
Nome
Charles River Laboratories International Inc
Settore
Industria
Telefono
781-222-6000
Indirizzo
251 BALLARDVALE ST, WILMINGTON, MA
Confronta CRL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
177.85 | 8.80B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-06 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-10-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-09-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-23 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-05-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-05-08 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-03-21 | Downgrade | Goldman | Buy → Neutral |
| 2025-03-04 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-03-03 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2025-01-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-11-18 | Downgrade | CLSA | Hold → Underperform |
| 2024-11-07 | Aggiornamento | CLSA | Underperform → Hold |
| 2024-10-23 | Iniziato | CLSA | Underperform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Sell |
| 2024-10-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-10-01 | Downgrade | Citigroup | Neutral → Sell |
| 2024-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-08-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Downgrade | Argus | Buy → Hold |
| 2024-06-07 | Iniziato | Mizuho | Neutral |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-09-13 | Iniziato | TD Cowen | Market Perform |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-02-23 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-01-12 | Downgrade | Jefferies | Buy → Hold |
| 2022-09-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-04 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | Iniziato | Guggenheim | Neutral |
| 2022-04-25 | Downgrade | Jefferies | Buy → Hold |
| 2022-04-07 | Iniziato | Stephens | Overweight |
| 2022-02-17 | Reiterato | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-02-17 | Reiterato | Deutsche Bank | Buy |
| 2022-02-17 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-17 | Reiterato | UBS | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-07-01 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-05-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-21 | Downgrade | Jefferies | Buy → Hold |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-02-18 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | Iniziato | SVB Leerink | Outperform |
| 2019-04-30 | Ripresa | Evercore ISI | Outperform |
| 2018-12-14 | Iniziato | Deutsche Bank | Buy |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-08-23 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Charles River Laboratories International Inc Borsa (CRL) Ultime notizie
Charles River Laboratories Q3 2025 Earnings Preview - MSN
Assetmark Inc. Purchases 18,557 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Will Charles River Laboratories' (CRL) ADC Partnership Redefine Its Edge in Biotech Collaboration? - simplywall.st
Using RSI to spot recovery in Charles River Laboratories International Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com
Is Charles River Laboratories International Inc. stock vulnerable to rate hikesTrend Reversal & Precise Buy Zone Identification - newser.com
Will Charles River Laboratories International Inc. stock maintain dividend yield2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
Can Charles River Laboratories International Inc. stock deliver double digit returnsJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Does Charles River Laboratories International Inc. (RV6) stock trade below intrinsic valueJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Will Charles River Laboratories International Inc. stock maintain growth storyJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
Can Charles River Laboratories International Inc. (RV6) stock withstand sector downturnsMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
How strong is Charles River Laboratories International Inc. (RV6) stock earnings growth2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
How Charles River Laboratories International Inc. stock moves on employment dataQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Tools to monitor Charles River Laboratories International Inc. recovery probabilityIPO Watch & Reliable Intraday Trade Plans - newser.com
Will Charles River Laboratories International Inc. (RV6) stock announce special dividendJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com
What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings - FinancialContent
What earnings revisions data tells us about Charles River Laboratories International Inc.Earnings Beat & High Conviction Buy Zone Picks - newser.com
Charles River Laboratories International Inc. stock chart pattern explainedMarket Volume Report & Technical Analysis for Trade Confirmation - newser.com
Signal strength of Charles River Laboratories International Inc. stock in tech scannersQuarterly Investment Review & Daily Stock Trend Reports - newser.com
Why hedge funds are buying Charles River Laboratories International Inc. stockJobs Report & Free Accurate Trade Setup Notifications - newser.com
Nicholas Company Inc. Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
How Charles River Laboratories International Inc. (RV6) stock valuation compares with sector2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Will Charles River Laboratories International Inc. stock benefit from green energy trendsTrend Reversal & Stepwise Trade Execution Plans - newser.com
What macro factors could drive Charles River Laboratories International Inc. (RV6) stock higherJuly 2025 Final Week & Verified Technical Signals - newser.com
Will Charles River Laboratories International Inc. stock benefit from commodity pricesTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Sector ETF performance correlation with Charles River Laboratories International Inc.M&A Rumor & Fast Exit Strategy with Risk Control - newser.com
What does recent volatility data suggest for Charles River Laboratories International Inc.July 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
Applying chart zones and confluence areas to Charles River Laboratories International Inc.Market Sentiment Report & Consistent Income Trade Recommendations - newser.com
Cooke & Bieler LP Increases Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 2,340 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Bessemer Group Inc. Cuts Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories (CRL): Exploring Valuation After New Drug Discovery Collaborations Boost Innovation Prospects - simplywall.st
UNIVEST FINANCIAL Corp Trims Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
How Recent Moves Are Rewriting the Story for Charles River Laboratories - Yahoo Finance
AlphaQuest LLC Invests $368,000 in Charles River Laboratories International, Inc. $CRL - MarketBeat
What to Expect From Charles River Laboratories' Q3 2025 Earnings Report - MSN
Why Charles River Laboratories International Inc. (RV6) stock is upgraded to buyEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How to integrate Charles River Laboratories International Inc. into portfolio analysis tools - newser.com
Charles River Laboratories International Inc Azioni (CRL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
6.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):